Understanding the Distinction Between Price Transparency, Affordability, and Medication Adherence
-
By
-
Catherine S. Hwang
-
Michael A. Steinman
-
October 5, 2026
Clinical Scorecard: Understanding the Distinction Between Price Transparency, Affordability, and Medication Adherence
At a Glance
| Category | Detail |
|---|
| Condition | Medication Adherence |
| Key Mechanisms | Real-time benefit tools (RTBTs) integrated into clinical workflows to provide patient-specific medication cost information. |
| Target Population | Patients requiring medication management. |
| Care Setting | Clinical settings utilizing electronic health records. |
Key Highlights
- RTBTs can reduce out-of-pocket expenses and improve medication fill rates.
- Clinicians have significant knowledge gaps regarding RTBTs and are open to further training.
- RTBTs may provide inaccurate information, leading to mistrust among clinicians.
- Medication adherence is influenced by multiple socioeconomic and health-related factors.
- RTBTs should not distract from addressing broader issues of medication affordability.
Guideline-Based Recommendations
Diagnosis
- Assess patient-specific factors influencing medication adherence.
Management
- Incorporate RTBTs into clinical workflows to facilitate cost discussions.
Monitoring & Follow-up
- Evaluate the accuracy and effectiveness of RTBTs in real-time clinical settings.
Risks
- Potential for RTBTs to divert attention from other important clinical issues.
Patient & Prescribing Data
Patients with varying socioeconomic backgrounds and medication needs.
Cost is one of several determinants affecting medication adherence.
Clinical Best Practices
- Engage in honest conversations with patients about barriers to medication adherence.
- Educate clinicians on the use and limitations of RTBTs.
- Address underlying factors influencing medication use behaviors.
Related Resources & Content
